Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025

Reuters

2025/08/29

Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025

Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2563017641"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563017641\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563017641?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 16:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563017641","market":"us","top_or_hot":-1,"title":"Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-29 16:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03689","symbol_name":"康華醫療","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL70xTHc:1","article_id":"2563017641","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563017641","pubTimestamp":1756456549,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Gro","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"03689":"康华医疗"},"translate_title":"广东康华医疗报告2025年上半年收入下降0.3%，利润降至人民币32.6百万元，每股收益为人民币12.5分","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03689":0.9},"content_text":"Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    \n\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}